Xiaoke Gu

625 total citations
34 papers, 544 citations indexed

About

Xiaoke Gu is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Xiaoke Gu has authored 34 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Infectious Diseases. Recurrent topics in Xiaoke Gu's work include Drug Transport and Resistance Mechanisms (12 papers), HIV/AIDS drug development and treatment (11 papers) and Cancer therapeutics and mechanisms (10 papers). Xiaoke Gu is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), HIV/AIDS drug development and treatment (11 papers) and Cancer therapeutics and mechanisms (10 papers). Xiaoke Gu collaborates with scholars based in China, United States and United Kingdom. Xiaoke Gu's co-authors include Hui Peng, Yihua Zhang, Zhiguang Ren, Sixun Peng, Xiaobo Tang, Yisheng Lai, Xiaoxing Yin, Jinyi Xu, Shengtao Xu and Qingqing Zhou and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Xiaoke Gu

34 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoke Gu China 14 285 185 146 62 48 34 544
Paul K. Spearing United States 9 208 0.7× 154 0.8× 242 1.7× 30 0.5× 42 0.9× 16 559
Ya‐Qiu Long China 18 380 1.3× 391 2.1× 99 0.7× 48 0.8× 36 0.8× 51 838
Sylvain Broussy France 16 424 1.5× 218 1.2× 75 0.5× 72 1.2× 82 1.7× 37 724
Heiner Glombik Germany 15 344 1.2× 134 0.7× 312 2.1× 45 0.7× 47 1.0× 24 713
Paige E. Mahaney United States 15 487 1.7× 320 1.7× 211 1.4× 22 0.4× 91 1.9× 27 1.0k
Michael C. Matelich United States 7 211 0.7× 335 1.8× 68 0.5× 109 1.8× 72 1.5× 9 606
Zunhua Yang China 17 368 1.3× 348 1.9× 105 0.7× 18 0.3× 20 0.4× 58 762
Manuela Labbozzetta Italy 18 474 1.7× 149 0.8× 180 1.2× 15 0.2× 24 0.5× 37 809
Bruno Cerra Italy 14 240 0.8× 193 1.0× 106 0.7× 12 0.2× 33 0.7× 37 571
Ki Deok Shin South Korea 7 404 1.4× 142 0.8× 186 1.3× 13 0.2× 33 0.7× 7 711

Countries citing papers authored by Xiaoke Gu

Since Specialization
Citations

This map shows the geographic impact of Xiaoke Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoke Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoke Gu more than expected).

Fields of papers citing papers by Xiaoke Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoke Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoke Gu. The network helps show where Xiaoke Gu may publish in the future.

Co-authorship network of co-authors of Xiaoke Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoke Gu. A scholar is included among the top collaborators of Xiaoke Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoke Gu. Xiaoke Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shuang, et al.. (2024). Discovery of novel third generation P-glycoprotein inhibitors bearing an azo moiety with MDR-reversing effect. European Journal of Medicinal Chemistry. 280. 116943–116943. 4 indexed citations
2.
Jiang, Chunyu, Ting Pan, Zhiyu Zhang, et al.. (2023). Design and evaluation of dibenzoazepine-tetrahydroisoquinoline hybrids as potential P-glycoprotein inhibitors against multidrug resistant K562/A02 cells. European Journal of Medicinal Chemistry. 249. 115150–115150. 8 indexed citations
3.
Wang, Fan, Xin Wang, Beibei Zhang, et al.. (2023). N-3, a novel synthetic derivative of bifendate, inhibits metastasis of triple-negative breast cancer via decreasing p38-regulated FOXC1 protein stability. Biochemical Pharmacology. 215. 115729–115729. 4 indexed citations
4.
Yang, Lihua, et al.. (2022). Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities. European Journal of Medicinal Chemistry. 244. 114833–114833. 11 indexed citations
5.
Zhou, Qingqing, et al.. (2022). Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect. European Journal of Medicinal Chemistry. 231. 114159–114159. 12 indexed citations
6.
Liu, Qingchuan, Chunyu Jiang, Qingqing Zhou, et al.. (2021). Synthesis and Evaluation of Novel Quinazolinone Derivatives as Potential Anti‐HCC Agents. Chemistry & Biodiversity. 19(2). e202100766–e202100766. 2 indexed citations
7.
Gu, Xiaoke, Xin Li, Mingyu Guan, et al.. (2020). Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells. Bioorganic & Medicinal Chemistry Letters. 30(24). 127638–127638. 11 indexed citations
8.
Zhou, Qingqing, Mingyu Guan, Xin Li, et al.. (2020). Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents. European Journal of Medicinal Chemistry. 205. 112581–112581. 7 indexed citations
9.
Gu, Xiaoke, et al.. (2020). Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents. Bioorganic & Medicinal Chemistry. 29. 115892–115892. 4 indexed citations
10.
Chen, Wang, Qingqing Zhou, Jing Chen, et al.. (2019). Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors. European Journal of Medicinal Chemistry. 176. 41–49. 13 indexed citations
11.
Chen, Wang, et al.. (2018). Assessment of a bifendate derivative bearing a 6,7-dihydro-dibenzo[c,e]azepine scaffold as a potential anti-metastatic agent. MedChemComm. 9(11). 1826–1830. 4 indexed citations
12.
Gu, Xiaoke, Yanfei Jiang, Jing Chen, et al.. (2018). Synthesis and biological evaluation of bifendate derivatives bearing acrylamide moiety as novel antioxidant agents. European Journal of Medicinal Chemistry. 162. 59–69. 7 indexed citations
13.
14.
Gao, Jian, et al.. (2017). Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. European Journal of Medicinal Chemistry. 144. 424–434. 12 indexed citations
15.
An, Lin, Lili Han, Youguang Zheng, et al.. (2016). Synthesis, X-ray crystal structure and anti-tumor activity of calix[n]arene polyhydroxyamine derivatives. European Journal of Medicinal Chemistry. 123. 21–30. 33 indexed citations
16.
Gu, Xiaoke, et al.. (2014). Discovery of alkoxyl biphenyl derivatives bearing dibenzo[c,e]azepine scaffold as potential dual inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorganic & Medicinal Chemistry Letters. 24(15). 3419–3421. 12 indexed citations
17.
Gu, Xiaoke, Zhiguang Ren, Xiaobo Tang, et al.. (2012). Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors. European Journal of Medicinal Chemistry. 51. 137–144. 31 indexed citations
18.
Tang, Xiaobo, Xiaoke Gu, Zhiguang Ren, et al.. (2012). Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents. Bioorganic & Medicinal Chemistry Letters. 22(8). 2675–2680. 16 indexed citations
19.
Gu, Xiaoke, Zhiguang Ren, Xiaobo Tang, et al.. (2012). Synthesis and biological evaluation of bifendate–chalcone hybrids as a new class of potential P-glycoprotein inhibitors. Bioorganic & Medicinal Chemistry. 20(8). 2540–2548. 36 indexed citations
20.
Tang, Xiaobo, Xiaoke Gu, Hua Ai, et al.. (2011). Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells. Bioorganic & Medicinal Chemistry Letters. 22(2). 801–805. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul K. Spearing Breakdown of academic impact, for papers by Ya‐Qiu Long Breakdown of academic impact, for papers by Sylvain Broussy Breakdown of academic impact, for papers by Heiner Glombik Breakdown of academic impact, for papers by Paige E. Mahaney Breakdown of academic impact, for papers by Michael C. Matelich Breakdown of academic impact, for papers by Zunhua Yang Breakdown of academic impact, for papers by Manuela Labbozzetta Breakdown of academic impact, for papers by Bruno Cerra Breakdown of academic impact, for papers by Ki Deok Shin
Rankless by CCL
2026